Morgan Stanley
TLSA icon

Morgan Stanley’s Tiziana Life Sciences TLSA Stock Holding History

Morgan Stanley’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.7K Buy
53,656
+1,500
+3% +$1.95K ﹤0.01% 6388
2026
Q1 		$61K Hold
52,156
– – ﹤0.01% 6344
2025
Q4 		$77.7K Sell
52,156
-44,946
-46% -$80.7K ﹤0.01% 6286
2025
Q3 		$210K Buy
97,102
+23,831
+33% +$44.1K ﹤0.01% 5867
2025
Q2 		$116K Sell
73,271
-65,761
-47% -$87.9K ﹤0.01% 6076
2025
Q1 		$150K Buy
139,032
+28,201
+25% +$27.6K ﹤0.01% 5847
2024
Q4 		$77.2K Buy
110,831
+1,084
+1% +$1K ﹤0.01% 6149
2024
Q3 		$105K Sell
109,747
-769
-0.7% -$777 ﹤0.01% 5985
2024
Q2 		$102K Sell
110,516
-15,622
-12% -$11.4K ﹤0.01% 5959
2024
Q1 		$57.3K Buy
126,138
+2,007
+2% +$1.05K ﹤0.01% 6161
2023
Q4 		$69.5K Sell
124,131
-3,503
-3% -$2.21K ﹤0.01% 6063
2023
Q3 		$84.2K Sell
127,634
-2,297
-2% -$1.58K ﹤0.01% 5965
2023
Q2 		$88.5K Buy
129,931
+11,806
+10% +$9.99K ﹤0.01% 6006
2023
Q1 		$129K Sell
118,125
-25,434
-18% -$16.6K ﹤0.01% 5909
2022
Q4 		$85.9K Sell
143,559
-38,441
-21% -$25.5K ﹤0.01% 6053
2022
Q3 		$142K Buy
182,000
+31,083
+21% +$23.4K ﹤0.01% 5899
2022
Q2 		$112K Buy
150,917
+56,057
+59% +$48.2K ﹤0.01% 6214
2022
Q1 		$100K Sell
94,860
-19,848
-17% -$17.6K ﹤0.01% 6312
2021
Q4 		$110K Sell
114,708
-64,753
-36% -$85.8K ﹤0.01% 6386
2021
Q3 		$262K Sell
179,461
-102,156
-36% -$189K ﹤0.01% 5861
2021
Q2 		$660K Sell
281,617
-16,246
-5% -$40.2K ﹤0.01% 5345
2021
Q1 		$825K Sell
297,863
-13,058
-4% -$43.3K ﹤0.01% 4842
2020
Q4 		$628K Sell
310,921
-39,084
-11% -$124K ﹤0.01% 4935
2020
Q3 		$1.17M Buy
350,005
+318,775
+1,021% +$1.24M ﹤0.01% 4097
2020
Q2 		$80K Buy
+31,230
New +$57.3K ﹤0.01% 5503

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
MAWAG
Mid-American Wealth Advisory Group Kansas City, Missouri $277M AUM 6.22% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Morgan Stanley's TLSA Position: Q2 2026 in Review

Morgan Stanley increased its Tiziana Life Sciences (TLSA) stake by 2.9% in Q2 2026, buying an estimated $1.95K and bringing the position to 53,656 shares worth $68.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6388.

Morgan Stanley first reported a position in TLSA in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.17M in Q3 2020. 31 funds tracked by Wall St. Rank hold TLSA as of Q2 2026.

  • Morgan Stanley held 53,656 shares of Tiziana Life Sciences worth $68.7K as of Q2 2026.
  • Morgan Stanley bought 1,500 Tiziana Life Sciences shares in Q2 2026, an estimated $1.95K.
  • Tiziana Life Sciences made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6388 holding.
  • Morgan Stanley first reported a position in Tiziana Life Sciences in Q2 2020 and has held it in 25 quarters since.
  • Morgan Stanley's Tiziana Life Sciences position peaked at $1.17M in Q3 2020.
  • 31 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.